Jason R. Clapper

1.6k total citations
17 papers, 1.3k citations indexed

About

Jason R. Clapper is a scholar working on Pharmacology, Cellular and Molecular Neuroscience and Surgery. According to data from OpenAlex, Jason R. Clapper has authored 17 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Pharmacology, 7 papers in Cellular and Molecular Neuroscience and 5 papers in Surgery. Recurrent topics in Jason R. Clapper's work include Cannabis and Cannabinoid Research (14 papers), Pancreatic function and diabetes (5 papers) and Forensic Toxicology and Drug Analysis (5 papers). Jason R. Clapper is often cited by papers focused on Cannabis and Cannabinoid Research (14 papers), Pancreatic function and diabetes (5 papers) and Forensic Toxicology and Drug Analysis (5 papers). Jason R. Clapper collaborates with scholars based in United States, Italy and Japan. Jason R. Clapper's co-authors include Daniele Piomelli, Marco Mor, Andrea Duranti, Andrea Tontini, Giorgio Tarzia, Federica Vacondio, Silvano Sanchini, Alvin R. King, Regina A. Mangieri and Andrea G. Hohmann and has published in prestigious journals such as Nature Neuroscience, Cell Metabolism and Biological Psychiatry.

In The Last Decade

Jason R. Clapper

17 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jason R. Clapper United States 16 816 384 277 218 212 17 1.3k
Natalya M. Kogan Israel 15 650 0.8× 202 0.5× 235 0.8× 115 0.5× 42 0.2× 27 974
Zhao-Hui Song United States 24 929 1.1× 590 1.5× 529 1.9× 89 0.4× 38 0.2× 54 1.4k
Nathalie Niederhoffer France 18 470 0.6× 214 0.6× 199 0.7× 80 0.4× 36 0.2× 33 1.1k
D. Dussossoy France 12 1.6k 1.9× 857 2.2× 470 1.7× 153 0.7× 39 0.2× 18 2.1k
María Gómez‐Cañas Spain 18 801 1.0× 367 1.0× 277 1.0× 86 0.4× 19 0.1× 33 1.1k
Jamie Boulet United States 11 410 0.5× 310 0.8× 184 0.7× 72 0.3× 24 0.1× 13 893
Haleli Sharir United States 14 641 0.8× 419 1.1× 514 1.9× 156 0.7× 16 0.1× 17 1.2k
Mai Hazekawa Japan 15 367 0.4× 173 0.5× 225 0.8× 65 0.3× 57 0.3× 47 931
Nicholas A. Jones United Kingdom 14 712 0.9× 535 1.4× 201 0.7× 58 0.3× 22 0.1× 27 1.1k
Nick M. Clayton United Kingdom 17 533 0.7× 383 1.0× 287 1.0× 20 0.1× 16 0.1× 43 1.2k

Countries citing papers authored by Jason R. Clapper

Since Specialization
Citations

This map shows the geographic impact of Jason R. Clapper's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jason R. Clapper with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jason R. Clapper more than expected).

Fields of papers citing papers by Jason R. Clapper

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jason R. Clapper. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jason R. Clapper. The network helps show where Jason R. Clapper may publish in the future.

Co-authorship network of co-authors of Jason R. Clapper

This figure shows the co-authorship network connecting the top 25 collaborators of Jason R. Clapper. A scholar is included among the top collaborators of Jason R. Clapper based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jason R. Clapper. Jason R. Clapper is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Cisar, Justin S., Jason R. Clapper, Jacqueline L. Blankman, et al.. (2018). Identification of ABX-1431, a Selective Inhibitor of Monoacylglycerol Lipase and Clinical Candidate for Treatment of Neurological Disorders. Journal of Medicinal Chemistry. 61(20). 9062–9084. 97 indexed citations
2.
Fraser, Iain D. C., Jacqueline L. Blankman, Jason R. Clapper, et al.. (2017). Preclinical characterization and first-in-human administration of a selective monoacylglycerol lipaseinhibitor, ABX-1431. Frontiers in Pharmacology. 8. 2 indexed citations
3.
Campbell, Christopher J., et al.. (2017). P‐198: Optically Clear Adhesives Enabling Foldable and Flexible OLED Displays. SID Symposium Digest of Technical Papers. 48(1). 2009–2011. 34 indexed citations
4.
Clapper, Jason R., Guibao Gu, Carrie Wittmer, et al.. (2013). Diet-induced mouse model of fatty liver disease and nonalcoholic steatohepatitis reflecting clinical disease progression and methods of assessment. American Journal of Physiology-Gastrointestinal and Liver Physiology. 305(7). G483–G495. 211 indexed citations
5.
Jung, Kwang‐Mook, Jason R. Clapper, Jin Fu, et al.. (2012). 2-Arachidonoylglycerol Signaling in Forebrain Regulates Systemic Energy Metabolism. Cell Metabolism. 15(3). 299–310. 81 indexed citations
6.
Clapper, Jason R., Jennifer Athanacio, Carrie Wittmer, et al.. (2012). Effects of amylin and bupropion/naltrexone on food intake and body weight are interactive in rodent models. European Journal of Pharmacology. 698(1-3). 292–298. 26 indexed citations
7.
Vacondio, Federica, Claudia Silva, Alessio Lodola, et al.. (2011). Biphenyl-3-yl alkylcarbamates as fatty acid amide hydrolase (FAAH) inhibitors: Steric effects of N-alkyl chain on rat plasma and liver stability. European Journal of Medicinal Chemistry. 46(9). 4466–4473. 20 indexed citations
8.
Clapper, Jason R., Guillermo Moreno‐Sanz, Roberto Russo, et al.. (2010). Anandamide suppresses pain initiation through a peripheral endocannabinoid mechanism. Nature Neuroscience. 13(10). 1265–1270. 268 indexed citations
9.
Eisenstein, Sarah A., Jason R. Clapper, Philip V. Holmes, Daniele Piomelli, & Andrea G. Hohmann. (2010). A role for 2-arachidonoylglycerol and endocannabinoid signaling in the locomotor response to novelty induced by olfactory bulbectomy. Pharmacological Research. 61(5). 419–429. 36 indexed citations
10.
Vacondio, Federica, Cláudia Silva, Alessio Lodola, et al.. (2009). Structure–Property Relationships of a Class of Carbamate‐Based Fatty Acid Amide Hydrolase (FAAH) Inhibitors: Chemical and Biological Stability. ChemMedChem. 4(9). 1495–1504. 40 indexed citations
11.
Clapper, Jason R., Federica Vacondio, Alvin R. King, et al.. (2009). A Second Generation of Carbamate‐Based Fatty Acid Amide Hydrolase Inhibitors with Improved Activity in vivo. ChemMedChem. 4(9). 1505–1513. 64 indexed citations
12.
Justinová, Zuzana, Regina A. Mangieri, Marco Bortolato, et al.. (2008). Fatty Acid Amide Hydrolase Inhibition Heightens Anandamide Signaling Without Producing Reinforcing Effects in Primates. Biological Psychiatry. 64(11). 930–937. 127 indexed citations
13.
Mor, Marco, Alessio Lodola, Silvia Rivara, et al.. (2008). Synthesis and Quantitative Structure−Activity Relationship of Fatty Acid Amide Hydrolase Inhibitors: Modulation at the N-Portion of Biphenyl-3-yl Alkylcarbamates. Journal of Medicinal Chemistry. 51(12). 3487–3498. 66 indexed citations
14.
Clapper, Jason R., Regina A. Mangieri, & Daniele Piomelli. (2008). The endocannabinoid system as a target for the treatment of cannabis dependence. Neuropharmacology. 56. 235–243. 56 indexed citations
15.
King, Alvin R., Andrea Duranti, Andrea Tontini, et al.. (2007). URB602 Inhibits Monoacylglycerol Lipase and Selectively Blocks 2-Arachidonoylglycerol Degradation in Intact Brain Slices. Chemistry & Biology. 14(12). 1357–1365. 85 indexed citations
16.
Tarzia, Giorgio, Andrea Duranti, Andrea Tontini, et al.. (2007). Identification of a Bioactive Impurity in a Commercial Sample of 6‐Methyl‐2‐p‐Tolylaminobenzo[d][1,3]Oxazin‐4‐One (URB754). Annali di Chimica. 97(9). 887–894. 20 indexed citations
17.
Clapper, Jason R., Andrea Duranti, Andrea Tontini, et al.. (2006). The fatty-acid amide hydrolase inhibitor URB597 does not affect triacylglycerol hydrolysis in rat tissues. Pharmacological Research. 54(5). 341–344. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Natalya M. Kogan Breakdown of academic impact, for papers by Zhao-Hui Song Breakdown of academic impact, for papers by Nathalie Niederhoffer Breakdown of academic impact, for papers by D. Dussossoy Breakdown of academic impact, for papers by María Gómez‐Cañas Breakdown of academic impact, for papers by Jamie Boulet Breakdown of academic impact, for papers by Haleli Sharir Breakdown of academic impact, for papers by Mai Hazekawa Breakdown of academic impact, for papers by Nicholas A. Jones Breakdown of academic impact, for papers by Nick M. Clayton
Rankless by CCL
2026